Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roopen Arya

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|November 9, 2020
Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolismWilliam Hinton, Banne Nemeth, Simon de Lusignan, et al.
BMC Hematology|August 26, 2016
Anticoagulated patient's perception of their illness, their beliefs about the anticoagulant therapy prescribed and the relationship with adherence: impact of novel oral anticoagulant therapy - study protocol for The Switching Study: a prospective cohort studyVivian Auyeung, Jignesh P Patel, John K Abdou, et al.
Emergency Medicine Journal : EMJ|July 26, 2024
King's lower limb immobilisation VTE risk assessment tool (K4 score) in conservatively treated ambulatory patients: a 2-year reviewElizabeth Marrinan, Victoria Speed, Gerard Giron, et al.
Research and Practice in Thrombosis and Haemostasis|November 3, 2022
Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registryStephanie Müller, Luise Tittl, Victoria Speed, et al.
Blood|August 4, 2020
Postdischarge venous thromboembolism following hospital admission with COVID-19Lara N Roberts, Martin B Whyte, Loizos Georgiou, et al.
Thrombosis Research|January 7, 2018
Exploration of adherence and patient experiences with DOACs one year after switching from vitamin-K antagonists- insights from the switching studyJohn K Bartoli-Abdou, Jignesh P Patel, Jacob Crawshaw, et al.
British Journal of Haematology|August 6, 2021
Rivaroxaban for the treatment of superficial vein thrombosis, experience at King's College HospitalRachel E Clapham, Victoria Speed, Julia Czuprynska, et al.
Thrombosis and Haemostasis|July 8, 2016
Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reportingJan Beyer-Westendorf, Franziska Michalski, Luise Tittl, et al.
Platelets|June 28, 2023
Hirudin versus citrate as an anticoagulant for ROTEM <i>platelet</i> whole blood impedance aggregometry in thrombocytopenic patientsWasanthi Wickramasinghe, Bhawani Yasassri Alvitigala, Thisarika Perera, et al.
Research and Practice in Thrombosis and Haemostasis|April 27, 2022
Rotational thromboelastometry in critical phase of dengue infection: Association with bleedingWasanthi Wickramasinghe, Bhawani Yasassri Alvitigala, Thisarika Perera, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Diabetic Medicine : a Journal of the British Diabetic Association|November 9, 2020
Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolismWilliam Hinton, Banne Nemeth, Simon de Lusignan, et al.
BMC Hematology|August 26, 2016
Anticoagulated patient's perception of their illness, their beliefs about the anticoagulant therapy prescribed and the relationship with adherence: impact of novel oral anticoagulant therapy - study protocol for The Switching Study: a prospective cohort studyVivian Auyeung, Jignesh P Patel, John K Abdou, et al.
Emergency Medicine Journal : EMJ|July 26, 2024
King's lower limb immobilisation VTE risk assessment tool (K4 score) in conservatively treated ambulatory patients: a 2-year reviewElizabeth Marrinan, Victoria Speed, Gerard Giron, et al.
Research and Practice in Thrombosis and Haemostasis|November 3, 2022
Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registryStephanie Müller, Luise Tittl, Victoria Speed, et al.
Blood|August 4, 2020
Postdischarge venous thromboembolism following hospital admission with COVID-19Lara N Roberts, Martin B Whyte, Loizos Georgiou, et al.
Thrombosis Research|January 7, 2018
Exploration of adherence and patient experiences with DOACs one year after switching from vitamin-K antagonists- insights from the switching studyJohn K Bartoli-Abdou, Jignesh P Patel, Jacob Crawshaw, et al.
British Journal of Haematology|August 6, 2021
Rivaroxaban for the treatment of superficial vein thrombosis, experience at King's College HospitalRachel E Clapham, Victoria Speed, Julia Czuprynska, et al.
Thrombosis and Haemostasis|July 8, 2016
Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reportingJan Beyer-Westendorf, Franziska Michalski, Luise Tittl, et al.
Platelets|June 28, 2023
Hirudin versus citrate as an anticoagulant for ROTEM <i>platelet</i> whole blood impedance aggregometry in thrombocytopenic patientsWasanthi Wickramasinghe, Bhawani Yasassri Alvitigala, Thisarika Perera, et al.
Research and Practice in Thrombosis and Haemostasis|April 27, 2022
Rotational thromboelastometry in critical phase of dengue infection: Association with bleedingWasanthi Wickramasinghe, Bhawani Yasassri Alvitigala, Thisarika Perera, et al.
Pageof 15